Copyright Reports & Markets. All rights reserved.

Global Liposomal Drug-delivery System Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Market Analysis by Type
    • 1.3.1 Global Liposomal Drug-delivery System Market Size Growth Rate by Type: 2020 VS 2026
    • 1.3.2 Liposome Vitamin
    • 1.3.3 Liposome Ceramide
    • 1.3.4 Liposome CoQ10
    • 1.3.5 Others
  • 1.4 Market by Application
    • 1.4.1 Global Liposomal Drug-delivery System Market Share by Application: 2020 VS 2026
    • 1.4.2 Medical
    • 1.4.3 Cosmetics
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Liposomal Drug-delivery System Market Perspective (2015-2026)
  • 2.2 Liposomal Drug-delivery System Growth Trends by Regions
    • 2.2.1 Liposomal Drug-delivery System Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Liposomal Drug-delivery System Historic Market Share by Regions (2015-2020)
    • 2.2.3 Liposomal Drug-delivery System Forecasted Market Size by Regions (2021-2026)
  • 2.3 Liposomal Drug-delivery System Industry Dynamic
    • 2.3.1 Liposomal Drug-delivery System Market Trends
    • 2.3.2 Liposomal Drug-delivery System Market Drivers
    • 2.3.3 Liposomal Drug-delivery System Market Challenges
    • 2.3.4 Liposomal Drug-delivery System Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Liposomal Drug-delivery System Players by Market Size
    • 3.1.1 Global Top Liposomal Drug-delivery System Players by Revenue (2015-2020)
    • 3.1.2 Global Liposomal Drug-delivery System Revenue Market Share by Players (2015-2020)
  • 3.2 Global Liposomal Drug-delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Liposomal Drug-delivery System Revenue
  • 3.4 Global Liposomal Drug-delivery System Market Concentration Ratio
    • 3.4.1 Global Liposomal Drug-delivery System Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Liposomal Drug-delivery System Revenue in 2019
  • 3.5 Key Players Liposomal Drug-delivery System Area Served
  • 3.6 Key Players Liposomal Drug-delivery System Product Solution and Service
  • 3.7 Date of Enter into Liposomal Drug-delivery System Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Liposomal Drug-delivery System Breakdown Data by Type

  • 4.1 Global Liposomal Drug-delivery System Historic Market Size by Type (2015-2020)
  • 4.2 Global Liposomal Drug-delivery System Forecasted Market Size by Type (2021-2026)

5 Liposomal Drug-delivery System Breakdown Data by Application

  • 5.1 Global Liposomal Drug-delivery System Historic Market Size by Application (2015-2020)
  • 5.2 Global Liposomal Drug-delivery System Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Liposomal Drug-delivery System Market Size (2015-2026)
  • 6.2 North America Liposomal Drug-delivery System Market Size by Type (2015-2020)
  • 6.3 North America Liposomal Drug-delivery System Market Size by Application (2015-2020)
  • 6.4 North America Liposomal Drug-delivery System Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Liposomal Drug-delivery System Market Size (2015-2026)
  • 7.2 Europe Liposomal Drug-delivery System Market Size by Type (2015-2020)
  • 7.3 Europe Liposomal Drug-delivery System Market Size by Application (2015-2020)
  • 7.4 Europe Liposomal Drug-delivery System Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Liposomal Drug-delivery System Market Size (2015-2026)
  • 8.2 Asia-Pacific Liposomal Drug-delivery System Market Size by Type (2015-2020)
  • 8.3 Asia-Pacific Liposomal Drug-delivery System Market Size by Application (2015-2020)
  • 8.4 Asia-Pacific Liposomal Drug-delivery System Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia

9 Latin America

  • 9.1 Latin America Liposomal Drug-delivery System Market Size (2015-2026)
  • 9.2 Latin America Liposomal Drug-delivery System Market Size by Type (2015-2020)
  • 9.3 Latin America Liposomal Drug-delivery System Market Size by Application (2015-2020)
  • 9.4 Latin America Liposomal Drug-delivery System Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Liposomal Drug-delivery System Market Size (2015-2026)
  • 10.2 Middle East & Africa Liposomal Drug-delivery System Market Size by Type (2015-2020)
  • 10.3 Middle East & Africa Liposomal Drug-delivery System Market Size by Application (2015-2020)
  • 10.4 Middle East & Africa Liposomal Drug-delivery System Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE

11Key Players Profiles

  • 11.1 Lipoid Kosmetik
    • 11.1.1 Lipoid Kosmetik Company Details
    • 11.1.2 Lipoid Kosmetik Business Overview
    • 11.1.3 Lipoid Kosmetik Liposomal Drug-delivery System Introduction
    • 11.1.4 Lipoid Kosmetik Revenue in Liposomal Drug-delivery System Business (2015-2020))
    • 11.1.5 Lipoid Kosmetik Recent Development
  • 11.2 Lucas Meyer Cosmetics
    • 11.2.1 Lucas Meyer Cosmetics Company Details
    • 11.2.2 Lucas Meyer Cosmetics Business Overview
    • 11.2.3 Lucas Meyer Cosmetics Liposomal Drug-delivery System Introduction
    • 11.2.4 Lucas Meyer Cosmetics Revenue in Liposomal Drug-delivery System Business (2015-2020)
    • 11.2.5 Lucas Meyer Cosmetics Recent Development
  • 11.3 Nippon Fine Chemical
    • 11.3.1 Nippon Fine Chemical Company Details
    • 11.3.2 Nippon Fine Chemical Business Overview
    • 11.3.3 Nippon Fine Chemical Liposomal Drug-delivery System Introduction
    • 11.3.4 Nippon Fine Chemical Revenue in Liposomal Drug-delivery System Business (2015-2020)
    • 11.3.5 Nippon Fine Chemical Recent Development
  • 11.4 Enoc Solutions
    • 11.4.1 Enoc Solutions Company Details
    • 11.4.2 Enoc Solutions Business Overview
    • 11.4.3 Enoc Solutions Liposomal Drug-delivery System Introduction
    • 11.4.4 Enoc Solutions Revenue in Liposomal Drug-delivery System Business (2015-2020)
    • 11.4.5 Enoc Solutions Recent Development
  • 11.5 Nanovec
    • 11.5.1 Nanovec Company Details
    • 11.5.2 Nanovec Business Overview
    • 11.5.3 Nanovec Liposomal Drug-delivery System Introduction
    • 11.5.4 Nanovec Revenue in Liposomal Drug-delivery System Business (2015-2020)
    • 11.5.5 Nanovec Recent Development
  • 11.6 Lipotec
    • 11.6.1 Lipotec Company Details
    • 11.6.2 Lipotec Business Overview
    • 11.6.3 Lipotec Liposomal Drug-delivery System Introduction
    • 11.6.4 Lipotec Revenue in Liposomal Drug-delivery System Business (2015-2020)
    • 11.6.5 Lipotec Recent Development
  • 11.7 Croda
    • 11.7.1 Croda Company Details
    • 11.7.2 Croda Business Overview
    • 11.7.3 Croda Liposomal Drug-delivery System Introduction
    • 11.7.4 Croda Revenue in Liposomal Drug-delivery System Business (2015-2020)
    • 11.7.5 Croda Recent Development
  • 11.8 H&A Pharmachem
    • 11.8.1 H&A Pharmachem Company Details
    • 11.8.2 H&A Pharmachem Business Overview
    • 11.8.3 H&A Pharmachem Liposomal Drug-delivery System Introduction
    • 11.8.4 H&A Pharmachem Revenue in Liposomal Drug-delivery System Business (2015-2020)
    • 11.8.5 H&A Pharmachem Recent Development
  • 11.9 Lipomize
    • 11.9.1 Lipomize Company Details
    • 11.9.2 Lipomize Business Overview
    • 11.9.3 Lipomize Liposomal Drug-delivery System Introduction
    • 11.9.4 Lipomize Revenue in Liposomal Drug-delivery System Business (2015-2020)
    • 11.9.5 Lipomize Recent Development
  • 11.10 ID bio
    • 11.10.1 ID bio Company Details
    • 11.10.2 ID bio Business Overview
    • 11.10.3 ID bio Liposomal Drug-delivery System Introduction
    • 11.10.4 ID bio Revenue in Liposomal Drug-delivery System Business (2015-2020)
    • 11.10.5 ID bio Recent Development
  • 11.11 BioSpectrum
    • 10.11.1 BioSpectrum Company Details
    • 10.11.2 BioSpectrum Business Overview
    • 10.11.3 BioSpectrum Liposomal Drug-delivery System Introduction
    • 10.11.4 BioSpectrum Revenue in Liposomal Drug-delivery System Business (2015-2020)
    • 10.11.5 BioSpectrum Recent Development
  • 11.12 Derma Clinical
    • 10.12.1 Derma Clinical Company Details
    • 10.12.2 Derma Clinical Business Overview
    • 10.12.3 Derma Clinical Liposomal Drug-delivery System Introduction
    • 10.12.4 Derma Clinical Revenue in Liposomal Drug-delivery System Business (2015-2020)
    • 10.12.5 Derma Clinical Recent Development
  • 11.13 Kewpie Corporation
    • 10.13.1 Kewpie Corporation Company Details
    • 10.13.2 Kewpie Corporation Business Overview
    • 10.13.3 Kewpie Corporation Liposomal Drug-delivery System Introduction
    • 10.13.4 Kewpie Corporation Revenue in Liposomal Drug-delivery System Business (2015-2020)
    • 10.13.5 Kewpie Corporation Recent Development
  • 11.14 Nanohealth Biotech
    • 10.14.1 Nanohealth Biotech Company Details
    • 10.14.2 Nanohealth Biotech Business Overview
    • 10.14.3 Nanohealth Biotech Liposomal Drug-delivery System Introduction
    • 10.14.4 Nanohealth Biotech Revenue in Liposomal Drug-delivery System Business (2015-2020)
    • 10.14.5 Nanohealth Biotech Recent Development
  • 11.15 Creative Biostructure
    • 10.15.1 Creative Biostructure Company Details
    • 10.15.2 Creative Biostructure Business Overview
    • 10.15.3 Creative Biostructure Liposomal Drug-delivery System Introduction
    • 10.15.4 Creative Biostructure Revenue in Liposomal Drug-delivery System Business (2015-2020)
    • 10.15.5 Creative Biostructure Recent Development
  • 11.16 Phenbiox
    • 10.16.1 Phenbiox Company Details
    • 10.16.2 Phenbiox Business Overview
    • 10.16.3 Phenbiox Liposomal Drug-delivery System Introduction
    • 10.16.4 Phenbiox Revenue in Liposomal Drug-delivery System Business (2015-2020)
    • 10.16.5 Phenbiox Recent Development
  • 11.17 NOF CORPORATION
    • 10.17.1 NOF CORPORATION Company Details
    • 10.17.2 NOF CORPORATION Business Overview
    • 10.17.3 NOF CORPORATION Liposomal Drug-delivery System Introduction
    • 10.17.4 NOF CORPORATION Revenue in Liposomal Drug-delivery System Business (2015-2020)
    • 10.17.5 NOF CORPORATION Recent Development
  • 11.18 KYOWA PHARMA CHEMICAL
    • 10.18.1 KYOWA PHARMA CHEMICAL Company Details
    • 10.18.2 KYOWA PHARMA CHEMICAL Business Overview
    • 10.18.3 KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Introduction
    • 10.18.4 KYOWA PHARMA CHEMICAL Revenue in Liposomal Drug-delivery System Business (2015-2020)
    • 10.18.5 KYOWA PHARMA CHEMICAL Recent Development
  • 11.19 Nikko Chemicals
    • 10.19.1 Nikko Chemicals Company Details
    • 10.19.2 Nikko Chemicals Business Overview
    • 10.19.3 Nikko Chemicals Liposomal Drug-delivery System Introduction
    • 10.19.4 Nikko Chemicals Revenue in Liposomal Drug-delivery System Business (2015-2020)
    • 10.19.5 Nikko Chemicals Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Liposomal Drug-delivery System market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Liposomal Drug-delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Liposome Vitamin
    Liposome Ceramide
    Liposome CoQ10
    Others

    Market segment by Application, split into
    Medical
    Cosmetics

    Based on regional and country-level analysis, the Liposomal Drug-delivery System market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    In the competitive analysis section of the report, leading as well as prominent players of the global Liposomal Drug-delivery System market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Lipoid Kosmetik
    Lucas Meyer Cosmetics
    Nippon Fine Chemical
    Enoc Solutions
    Nanovec
    Lipotec
    Croda
    H&A Pharmachem
    Lipomize
    ID bio
    BioSpectrum
    Derma Clinical
    Kewpie Corporation
    Nanohealth Biotech
    Creative Biostructure
    Phenbiox
    NOF CORPORATION
    KYOWA PHARMA CHEMICAL

    Buy now